BARDS plays a vital role in advancing end-to-end product research, development, regulatory approval, and patient access by collaborating with scientists across disciplines to help deliver impactful medicines and vaccines. Our work supports a broad and dynamic pipeline, including treatments for oncology, infectious diseases, cardio-metabolic disorders, and more.